Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Escherichia Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Post-approval studies (Phase 4)Study completedNCT04049994
What this trial is testing

Immunomodulation Therapy for Urinary Tract Infections

Who this might be right for
Spinal Cord InjuriesUrinary Tract Infections
Swiss Paraplegic Research, Nottwil 24
Testing effectiveness (Phase 2)Study completedNCT03819049
What this trial is testing

Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Who this might be right for
Extraintestinal Pathogenic Escherichia Coli Prevention
Janssen Research & Development, LLC 836
Testing effectiveness (Phase 2)Study completedNCT01060748
What this trial is testing

Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea

Who this might be right for
Diarrhea
TD Vaccines A/S 70
Early research (Phase 1)Study completedNCT00654108
What this trial is testing

Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 62
Not applicableStudy completedNCT00914576
What this trial is testing

Effect of Antioxidants on Oxygen Induced Vasoconstriction in Lipopolysaccharide (LPS) Induced Inflammatory Model in Humans

Who this might be right for
Healthy
Medical University of Vienna 40
Not applicableStudy completedNCT01225042
What this trial is testing

The Effect of Probiotics on E. Coli Gastroenteritis

Who this might be right for
GastroenteritisBacterial InfectionDiarrhea
NIZO Food Research 40
Not applicableStudy completedNCT04574596
What this trial is testing

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Who this might be right for
E Coli Infection
Duke University 300
Not applicableWithdrawnNCT00619580
What this trial is testing

Ampicillin-sulbactam Resistant E.Coli at UPMC

Who this might be right for
Positive E Coli Infections
University of Pittsburgh
Post-approval studies (Phase 4)Ended earlyNCT02176122
What this trial is testing

RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.

Who this might be right for
Bloodstream Infections
The University of Queensland 391
Early research (Phase 1)Study completedNCT06896136
What this trial is testing

Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA

Who this might be right for
Diarrhea Infectious
Mark Klempner 36
Early research (Phase 1)Study completedNCT02052934
What this trial is testing

Safety of Sublingual dmLT for ETEC

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT02847065
What this trial is testing

The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421

Who this might be right for
Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
Nantes University Hospital 144
Not applicableLooking for participantsNCT05826067
What this trial is testing

Study of E. Coli Isolates From Recurrent Urinary Tract Infections

Who this might be right for
Urinary Tract InfectionsPatients With Suprabubic CatheterPatients With Nephrostomy Catheter
Université Catholique de Louvain 45
Large-scale testing (Phase 3)Study completedNCT00328380
What this trial is testing

Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.

Who this might be right for
Diarrhea
Bausch Health Americas, Inc. 660
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808103
What this trial is testing

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

Who this might be right for
Crohn Disease
Intralytix, Inc. 30
Not applicableStudy completedNCT01961206
What this trial is testing

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Who this might be right for
Community Acquired Infection
Jian-cang Zhou M.D. 960
Large-scale testing (Phase 3)Study completedNCT01410916
What this trial is testing

Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)

Who this might be right for
Shiga-like Toxin-producing Escherichia Coli
Alexion Pharmaceuticals, Inc. 198
Post-approval studies (Phase 4)Study completedNCT02584543
What this trial is testing

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Who this might be right for
Hepatitis EHepatitis B
Xiamen Innovax Biotech Co., Ltd 602
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Next Page